Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Rigel Pharmaceuticals Total Current Assets 2010-2024 | RIGL

Rigel Pharmaceuticals total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  
Rigel Pharmaceuticals Annual Total Current Assets
(Millions of US $)
2023 $99
2022 $116
2021 $154
2020 $89
2019 $119
2018 $137
2017 $117
2016 $76
2015 $129
2014 $151
2013 $220
2012 $302
2011 $250
2010 $180
2009 $136
Rigel Pharmaceuticals Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $95
2024-03-31 $92
2023-12-31 $99
2023-09-30 $95
2023-06-30 $101
2023-03-31 $107
2022-12-31 $116
2022-09-30 $110
2022-06-30 $121
2022-03-31 $139
2021-12-31 $154
2021-09-30 $171
2021-06-30 $184
2021-03-31 $197
2020-12-31 $89
2020-09-30 $100
2020-06-30 $113
2020-03-31 $116
2019-12-31 $119
2019-09-30 $126
2019-06-30 $125
2019-03-31 $139
2018-12-31 $137
2018-09-30 $121
2018-06-30 $139
2018-03-31 $97
2017-12-31 $117
2017-09-30 $70
2017-06-30 $84
2017-03-31 $100
2016-12-31 $76
2016-09-30 $87
2016-06-30 $97
2016-03-31 $106
2015-12-31 $129
2015-09-30 $136
2015-06-30 $146
2015-03-31 $163
2014-12-31 $151
2014-09-30 $159
2014-06-30 $178
2014-03-31 $198
2013-12-31 $220
2013-09-30 $233
2013-06-30 $255
2013-03-31 $275
2012-12-31 $302
2012-09-30 $187
2012-06-30 $206
2012-03-31 $226
2011-12-31 $250
2011-09-30 $269
2011-06-30 $283
2011-03-31 $158
2010-12-31 $180
2010-09-30 $195
2010-06-30 $190
2010-03-31 $212
2009-12-31 $136
2009-09-30 $159
2009-06-30 $83
2009-03-31 $108
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.388B $0.117B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.775B 30.70
Takeda Pharmaceutical (TAK) Japan $43.846B 9.13
Merck (MKKGY) Germany $21.021B 22.94
Astellas Pharma (ALPMY) Japan $20.214B 18.62
Sandoz Group AG (SDZNY) Switzerland $19.826B 0.00
United Therapeutics (UTHR) United States $18.304B 18.01
Summit Therapeutics (SMMT) United States $15.789B 0.00
Neurocrine Biosciences (NBIX) United States $12.731B 33.71
Shionogi (SGIOY) Japan $12.473B 11.95
Catalent (CTLT) United States $10.784B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.649B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.633B 7.31
Orion OYJ (ORINY) Finland $6.848B 19.25
Corcept Therapeutics (CORT) United States $6.245B 47.30
Ionis Pharmaceuticals (IONS) United States $6.188B 0.00
Crinetics Pharmaceuticals (CRNX) United States $4.857B 0.00
PTC Therapeutics (PTCT) United States $3.406B 0.00
Dyne Therapeutics (DYN) United States $2.859B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.854B 12.94
Arrowhead Pharmaceuticals (ARWR) United States $2.721B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.702B 16.17
Soleno Therapeutics (SLNO) United States $2.460B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.171B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.996B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.870B 0.00
Harrow (HROW) United States $1.863B 0.00
Ocular Therapeutix (OCUL) United States $1.731B 0.00
Xencor (XNCR) United States $1.653B 0.00
ARS Pharmaceuticals (SPRY) United States $1.652B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.611B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.535B 0.00
Evotec AG (EVO) Germany $1.464B 0.00
Indivior (INDV) United States $1.413B 5.76
Enliven Therapeutics (ELVN) United States $1.368B 0.00
Guardian Pharmacy Services (GRDN) United States $1.329B 0.00
Cassava Sciences (SAVA) United States $1.293B 0.00
Ardelyx (ARDX) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.190B 0.00
Collegium Pharmaceutical (COLL) United States $1.036B 5.66
Bioventus (BVS) United States $0.957B 30.31
Relay Therapeutics (RLAY) United States $0.830B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.792B 0.00
USANA Health Sciences (USNA) United States $0.767B 14.22
Cronos Group (CRON) Canada $0.765B 0.00
Tourmaline Bio (TRML) United States $0.737B 0.00
Exscientia (EXAI) United Kingdom $0.658B 0.00
Korro Bio (KRRO) United States $0.655B 0.00
Savara (SVRA) United States $0.653B 0.00
ProKidney (PROK) United States $0.579B 0.00
Larimar Therapeutics (LRMR) United States $0.569B 0.00
Altimmune (ALT) United States $0.546B 0.00
Elite Pharmaceuticals (ELTP) United States $0.545B 50.98
Siga Technologies (SIGA) United States $0.540B 6.31
Verve Therapeutics (VERV) United States $0.534B 0.00
OmniAb (OABI) United States $0.534B 0.00
Silence Therapeutics (SLN) United Kingdom $0.524B 0.00
Xeris Biopharma Holdings (XERS) United States $0.517B 0.00
Aquestive Therapeutics (AQST) United States $0.498B 0.00
KalVista Pharmaceuticals (KALV) United States $0.493B 0.00
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.456B 0.00
Esperion Therapeutics (ESPR) United States $0.447B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.437B 0.00
Organogenesis (ORGO) United States $0.435B 0.00
4D Molecular Therapeutics (FDMT) United States $0.422B 0.00
Akebia Therapeutics (AKBA) United States $0.408B 0.00
Sage Therapeutics (SAGE) United States $0.386B 0.00
Aldeyra Therapeutics (ALDX) United States $0.328B 0.00
Lyell Immunopharma (LYEL) United States $0.312B 0.00
Avita Medical (RCEL) United States $0.311B 0.00
Nature's Sunshine Products (NATR) United States $0.276B 16.37
Acrivon Therapeutics (ACRV) United States $0.265B 0.00
Heron Therapeutics (HRTX) United States $0.265B 0.00
Lexeo Therapeutics (LXEO) United States $0.264B 0.00
Pyxis Oncology (PYXS) United States $0.263B 0.00
Nektar Therapeutics (NKTR) United States $0.258B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.235B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.226B 0.00
Profound Medical (PROF) Canada $0.216B 0.00
Nanobiotix S.A (NBTX) France $0.198B 0.00
Aclaris Therapeutics (ACRS) United States $0.189B 0.00
Galectin Therapeutics (GALT) United States $0.187B 0.00
MediWound (MDWD) Israel $0.186B 0.00
Innate Pharma SA (IPHYF) France $0.180B 0.00
Incannex Healthcare (IXHL) Australia $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.159B 0.00
Cardiol Therapeutics (CRDL) Canada $0.159B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Context Therapeutics (CNTX) United States $0.146B 0.00
Telomir Pharmaceuticals (TELO) United States $0.125B 0.00
Century Therapeutics (IPSC) United States $0.122B 0.00
VAXART, INC (VXRT) United States $0.122B 0.00
Fractyl Health (GUTS) United States $0.118B 0.00
OptiNose (OPTN) United States $0.118B 0.00
Journey Medical (DERM) United States $0.117B 0.00
Karyopharm Therapeutics (KPTI) United States $0.110B 0.00
Relmada Therapeutics (RLMD) United States $0.099B 0.00
Regulus Therapeutics (RGLS) United States $0.096B 0.00
Arch Biopartners (ACHFF) Canada $0.094B 0.00
PMV Pharmaceuticals (PMVP) United States $0.090B 0.00
ElectroCore (ECOR) United States $0.087B 0.00
CASI Pharmaceuticals (CASI) China $0.085B 0.00
Assertio Holdings (ASRT) United States $0.081B 14.17
ESSA Pharma (EPIX) Canada $0.080B 0.00
Inotiv (NOTV) United States $0.078B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 368.67
Metagenomi (MGX) United States $0.076B 0.00
Citius Pharmaceuticals (CTXR) United States $0.074B 0.00
AlloVir (ALVR) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Prelude Therapeutics (PRLD) United States $0.065B 0.00
Champions Oncology (CSBR) United States $0.061B 0.00
Mural Oncology (MURA) Ireland $0.060B 0.00
Nutriband (NTRB) United States $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.056B 0.00
BGM Group (BGM) China $0.053B 0.00
Protara Therapeutics (TARA) United States $0.052B 0.00
SCYNEXIS (SCYX) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.048B 0.00
VYNE Therapeutics (VYNE) United States $0.047B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
DURECT (DRRX) United States $0.041B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
BioLineRx (BLRX) Israel $0.036B 0.00
Surrozen (SRZN) United States $0.033B 0.00
FibroGen (FGEN) United States $0.032B 0.00
Oruka Therapeutics (ORKA) United States $0.032B 0.00
Iterum Therapeutics (ITRM) Ireland $0.032B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.031B 0.00
Natural Alternatives (NAII) United States $0.028B 0.00
Tempest Therapeutics (TPST) United States $0.027B 0.00
GlycoMimetics (GLYC) United States $0.027B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
BioVie (BIVI) United States $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
Inhibikase Therapeutics (IKT) United States $0.022B 0.00
MEI Pharma (MEIP) United States $0.020B 0.71
Tonix Pharmaceuticals Holding (TNXP) United States $0.019B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.019B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Lyra Therapeutics (LYRA) United States $0.018B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Talphera (TLPH) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Nuvilex (PMCB) United States $0.014B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
Indaptus Therapeutics (INDP) United States $0.012B 0.00
Addex Therapeutics (ADXN) Switzerland $0.011B 0.00
CERo Therapeutics Holdings (CERO) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Conduit Pharmaceuticals (CDT) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.009B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.005B 0.00
Ainos (AIMD) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.09
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 2.98
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.71